DiscoverNEJM InterviewsNEJM Interview: Ashish Jha on an investment by the Biden administration in the development of next-generation vaccines and treatments for SARS-CoV-2.
NEJM Interview: Ashish Jha on an investment by the Biden administration in the development of next-generation vaccines and treatments for SARS-CoV-2.

NEJM Interview: Ashish Jha on an investment by the Biden administration in the development of next-generation vaccines and treatments for SARS-CoV-2.

Update: 2023-08-30
Share

Description

Ashish Jha is the dean of the Brown University School of Public Health and the former White House Covid-19 response coordinator. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. X. Becerra and A. Jha. Project NextGen — Defeating SARS-CoV-2 and Preparing for the Next Pandemic. N Engl J Med 2023;389:77 3-775.
Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

NEJM Interview: Ashish Jha on an investment by the Biden administration in the development of next-generation vaccines and treatments for SARS-CoV-2.

NEJM Interview: Ashish Jha on an investment by the Biden administration in the development of next-generation vaccines and treatments for SARS-CoV-2.